Neurostimulation for Parkinson's disease with early motor complications WMM Schuepbach, J Rau, K Knudsen, J Volkmann, P Krack, ... New England Journal of Medicine 368 (7), 610-622, 2013 | 1469 | 2013 |
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007 | 262 | 2007 |
Longitudinal analysis of impulse control disorders in Parkinson disease JC Corvol, F Artaud, F Cormier-Dequaire, O Rascol, F Durif, ... Neurology 91 (3), e189-e201, 2018 | 225 | 2018 |
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo … C Moreau, A Delval, L Defebvre, K Dujardin, A Duhamel, G Petyt, ... The lancet neurology 11 (7), 589-596, 2012 | 214 | 2012 |
Levodopa-carbidopa intestinal gel in advanced Parkinson's: final results of the GLORIA registry A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ... Parkinsonism & related disorders 45, 13-20, 2017 | 188 | 2017 |
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ... Neurology 82 (4), 300-307, 2014 | 158 | 2014 |
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ... The Lancet Neurology 16 (8), 620-629, 2017 | 147 | 2017 |
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial … E Lhommée, L Wojtecki, V Czernecki, K Witt, F Maier, L Tonder, ... The Lancet Neurology 17 (3), 223-231, 2018 | 138 | 2018 |
Does ageing influence deep brain stimulation outcomes in Parkinson's disease? F Ory‐Magne, C Brefel‐Courbon, M Simonetta‐Moreau, N Fabre, ... Movement disorders: official journal of the Movement Disorder Society 22 (10 …, 2007 | 126 | 2007 |
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial GU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ... The Lancet Neurology 20 (3), 182-192, 2021 | 102 | 2021 |
Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study E Dellapina, A Gerdelat‐Mas, F Ory‐Magne, L Pourcel, M Galitzky, ... Movement Disorders 26 (1), 153-157, 2011 | 102 | 2011 |
International validation of a behavioral scale in Parkinson's disease without dementia I Rieu, P Martinez‐Martin, B Pereira, I De Chazeron, L Verhagen Metman, ... Movement Disorders 30 (5), 705-713, 2015 | 93 | 2015 |
Quality of life predicts outcome of deep brain stimulation in early Parkinson disease WMM Schuepbach, L Tonder, A Schnitzler, P Krack, J Rau, A Hartmann, ... Neurology 92 (10), e1109-e1120, 2019 | 91 | 2019 |
Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease C Brefel-Courbon, F Ory-Magne, C Thalamas, P Payoux, O Rascol Parkinsonism & Related Disorders 19 (5), 548-552, 2013 | 88 | 2013 |
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia H Pouclet-Courtemanche, T Rouaud, S Thobois, JM Nguyen, ... Neurology 86 (7), 651-659, 2016 | 86 | 2016 |
Exchangeable copper: a reflection of the neurological severity in W ilson's disease A Poujois, JM Trocello, N Djebrani‐Oussedik, J Poupon, C Collet, ... European Journal of Neurology 24 (1), 154-160, 2017 | 85 | 2017 |
Effect of subthalamic deep brain stimulation on pain in Parkinson’s disease E Dellapina, F Ory-Magne, W Regragui, C Thalamas, Y Lazorthes, ... PAIN® 153 (11), 2267-2273, 2012 | 81 | 2012 |
Trial of deferiprone in Parkinson’s disease D Devos, J Labreuche, O Rascol, JC Corvol, A Duhamel, ... New England Journal of Medicine 387 (22), 2045-2055, 2022 | 68 | 2022 |
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease C Moreau, S Meguig, JC Corvol, J Labreuche, F Vasseur, A Duhamel, ... Brain 138 (5), 1271-1283, 2015 | 66 | 2015 |
Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease J Pellaprat, F Ory-Magne, C Canivet, M Simonetta-Moreau, JA Lotterie, ... Parkinsonism & related disorders 20 (6), 662-664, 2014 | 60 | 2014 |